GT Biopharma (GTBP) Prepaid Assets (2010 - 2026)
GT Biopharma (GTBP) reported Prepaid Assets of $409,000 for Q1 2026, up 104.5% from $200,000 a year earlier but down 27.9% from the prior quarter.
Powered by 
Analysis
GT Biopharma (GTBP) Prepaid Assets (2010 - 2026) Analysis & Trends
At the end of FY2025, GT Biopharma posted Prepaid Assets of $567,000, up 201.6% from FY2024.
- Prepaid Assets has increased for three consecutive years, with a five-year compound annual growth rate of 9.3% (FY2020 to FY2025).
- By year, Prepaid Assets came in at $188,000 in FY2024 (+123.8%), $84,000 in FY2023 (+55.6%), $54,000 in FY2022 (-71.6%) and $190,000 in FY2021 (-47.8%).
- Five-year quarterly Prepaid Assets spans a low of $38,000 in Q1 2023 and a high of $1.04 million in Q2 2025.
- Year over year, Prepaid Assets has now increased in each of the last three quarters, with growth averaging 236.3% over the last six quarters.
- The high point for year-over-year Prepaid Assets in five years was Q3 2024 (growth of 552.6%); the low point was Q1 2023 (a decline of 91.6%).
- Per Business Quant data, the three quarters before Q1 2026 came in at $567,000 (Q4 2025), $940,000 (Q3 2025) and $1.04 million (Q2 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | GT Biopharma | 9.11 Mn | 9.11 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 409,000.00 |
| Dec 31, 2025 | 567,000.00 |
| Sep 30, 2025 | 940,000.00 |
| Jun 30, 2025 | 1.04 Mn |
| Mar 31, 2025 | 200,000.00 |
| Dec 31, 2024 | 188,000.00 |
| Sep 30, 2024 | 248,000.00 |
| Mar 31, 2024 | 78,000.00 |
| Dec 31, 2023 | 84,000.00 |
| Sep 30, 2023 | 38,000.00 |
| Jun 30, 2023 | 48,000.00 |
| Mar 31, 2023 | 38,000.00 |
| Dec 31, 2022 | 54,000.00 |
| Sep 30, 2022 | 88,000.00 |
| Jun 30, 2022 | 222,000.00 |
| Mar 31, 2022 | 453,000.00 |
| Dec 31, 2021 | 190,000.00 |
| Sep 30, 2021 | 85,000.00 |
| Jun 30, 2021 | 62,000.00 |
| Mar 31, 2021 | 88,000.00 |
API Access
GT Biopharma Prepaid Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=prepaid-assets&ticker=GTBP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "prepaid-assets", "ticker": "GTBP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=prepaid-assets&ticker=GTBP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();